Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Medicamen Biotech Limited (NSE: MEDICAMEQ), ISIN INE646B01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MEDICAMEQ last traded at ₹284.95 (+3.36%), with a 52-week range of ₹212.40 to ₹447.65 (as of 6 Nov 2026).
Shareholding as of Dec 2026: promoters 42.57%, FIIs 4.35%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 50/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.